Eli Lilly and Company announced it is investing $2.1 billion to expand its manufacturing footprint with the addition of two new manufacturing sites in Indiana.

These new facilities, which will be in the LEAP Lebanon Innovation and Research District in Boone County, Indiana, will expand Lilly’s manufacturing network for active ingredients and new therapeutic modalities, such as genetic medicines and support Lilly’s existing products and the company’s clinical pipeline. The proposed project is expected to create up to 500 new roles at the company.

Lilly’s most recent expansion in Indiana was announced in 2019 and capped a series of investments in research and manufacturing in and around Indianapolis. Those investments totaled more than $2.5 billion over five years and created additional manufacturing jobs bringing the total current number of Lilly manufacturing employees in Indiana to more than 3,700.

The investment in Boone County is contingent upon local zoning and annexation approvals.

Source: Eli Lilly and Company